El tratamiento con quimioterapia hoy en pacientes HER2 negativo: el papel de la eribulina - page 41

Eribulin mesylate

(E7389) +

PEGylated recombinant human

hyaluronidase

(PEGPH20) in HER2-negative, high-

hyaluronan (HA), metastatic breast cancer (mBC)

Study Design

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,31,32,33,34,35,36,37,38,39,40 42,43